Skip to content
Back to Guavy Wire
Stocks

P&G Buys Thorne for $3.8 Billion to Enter Health and Wellness Market

Instruments
PG
Share

Procter & Gamble (NYSE:PG) has agreed to purchase Thorne, a premium health and wellness supplement brand, for approximately $3.8 billion. This deal marks P&G's further push into self-care and preventative health, expanding its reach beyond traditional household products.

The acquisition values Thorne at about $3.8 billion, giving P&G exposure to a different type of customer relationship through the brand's direct-to-consumer subscription model and focus on practitioner-trusted supplements.

This move aligns with the shift in consumer spending toward self-care and preventative health products. As a result, investors may want to monitor how P&G allocates capital, develops its wellness offerings, and competes with other consumer health companies over time.

More on Stocks

Disclaimer: Guavy is a data and market intelligence provider, not an investment advisor. The information, signals, and market analysis provided by the Guavy API and related services are for informational purposes only and are not intended as financial advice, investment recommendations, or an endorsement of any particular trading strategy. Trading in volatile markets, including cryptocurrency, carries significant risk and may not be suitable for all investors. Past performance is not indicative of future results. Users should consult with a qualified financial professional before making any investment decisions. Guavy makes no guarantee of trading profits or financial returns.

Market sentiment intelligence for apps, funds & agents

Location

729 55 Ave SW
Calgary AB T2V 0G4
Canada

© 2026 Guavy Inc